10 Recruiting Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Cancer studiesPhase 1 / Phase 2 Studies for Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
📍 Cedars Sinai-The Angeles Clinic — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
📍 Stanford University Cancer Institute — Stanford, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
📍 UCLA Health — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
📍 NEXT Austin — Austin, Texas
View Study & Checklist ➔